Fuchs spot

From WikiMD's Medical Encyclopedia

Revision as of 18:23, 6 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Fuchs' spot
OCT image of the retina
Synonyms Forster-Fuchs' spot
Pronounce N/A
Specialty N/A
Symptoms Visual impairment, central scotoma
Complications Choroidal neovascularization, retinal detachment
Onset Typically in adolescence or young adulthood
Duration Chronic
Types N/A
Causes Pathologic myopia
Risks High myopia, genetic predisposition
Diagnosis Fundoscopy, optical coherence tomography
Differential diagnosis Macular degeneration, central serous retinopathy
Prevention N/A
Treatment Anti-VEGF therapy, laser photocoagulation
Medication N/A
Prognosis Variable, depends on severity and treatment
Frequency Rare
Deaths N/A


Fuchs' spot is a condition associated with the eye that is often seen in patients with high levels of myopia (nearsightedness). It is named after the Austrian ophthalmologist Ernst Fuchs, who first described the condition in the early 20th century. Fuchs' spot is characterized by a focal area of chorioretinal atrophy and pigmentation in the macula, the part of the retina responsible for sharp central vision.

Causes and Pathophysiology[edit]

Fuchs' spot is primarily associated with pathological myopia, a severe form of myopia that can lead to significant visual impairment. In patients with pathological myopia, the eyeball elongates excessively, which can cause stretching and thinning of the sclera, choroid, and retina. This stretching can lead to breaks in the Bruch's membrane, which is part of the choroid layer, leading to the development of neovascularization (the growth of new blood vessels) beneath the retina. These new vessels are often fragile and prone to leakage, which can result in the formation of a Fuchs' spot.

Symptoms[edit]

The primary symptom of a Fuchs' spot is a decrease in central vision. This can manifest as blurred vision, a dark spot in the center of the visual field, or difficulty reading. The severity of vision loss can vary depending on the size and location of the spot. In some cases, patients may not notice any symptoms, especially if the spot is small or located away from the central macula.

Diagnosis[edit]

Diagnosis of Fuchs' spot typically involves a comprehensive eye examination, including visual acuity testing and a dilated fundus examination. Imaging techniques such as optical coherence tomography (OCT) and fluorescein angiography can also be used to assess the extent of chorioretinal atrophy and the presence of neovascularization.

Treatment[edit]

Treatment options for Fuchs' spot are limited and primarily aimed at managing the underlying myopia and preventing further progression of the condition. This may include the use of corrective lenses or refractive surgery to correct the myopia. In cases where neovascularization is present, treatments such as laser photocoagulation or injections of anti-vascular endothelial growth factor (anti-VEGF) medications may be used to reduce the risk of bleeding and further vision loss.

Prognosis[edit]

The prognosis for patients with Fuchs' spot varies. While the condition can lead to significant vision loss, early detection and treatment of neovascularization can help to stabilize vision and prevent further deterioration. Patients with Fuchs' spot should undergo regular eye examinations to monitor the condition and manage any complications that arise.

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.